A M Kaunitz

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, Florida, USA
    Obstet Gynecol 114:1205-12. 2009
  2. ncbi The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, FL 32209, USA
    Drugs 72:193-215. 2012
  3. ncbi Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
    Obstet Gynecol 116:625-32. 2010
  4. ncbi Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32209, USA
    Contraception 74:90-9. 2006
  5. ncbi Enhancing oral contraceptive success: the potential of new formulations
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32209, USA
    Am J Obstet Gynecol 190:S23-9. 2004
  6. ncbi Progestin-releasing intrauterine systems and leiomyoma
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, FL 32209, USA
    Contraception 75:S130-3. 2007
  7. ncbi Gynecologic problems of the perimenopause: evaluation and treatment
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209, USA
    Obstet Gynecol Clin North Am 29:455-73. 2002
  8. ncbi Noncontraceptive health benefits of oral contraceptives
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32257, USA
    Rev Endocr Metab Disord 3:277-83. 2002
  9. ncbi Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Forida College of Medicine Jacksonville, FL 32209, USA
    Menopause 14:941-3. 2007
  10. ncbi Menstruation: choosing whether...and when
    A M Kaunitz
    University of Florida Health Science Center, Jacksonville, FL 32557, USA
    Contraception 62:277-84. 2000

Detail Information

Publications61

  1. ncbi Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, Florida, USA
    Obstet Gynecol 114:1205-12. 2009
    ..To compare bleeding patterns between a 21/7-day triphasic norgestimate/ethinyl estradiol (E2) 25-microgram oral contraceptive pill (OCP) and a 24/4-day drospirenone/ethinyl E2 20-microgram OCP...
  2. ncbi The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, FL 32209, USA
    Drugs 72:193-215. 2012
    ..In conclusion, the LNG-IUS is an effective treatment option for women with HMB, including those with underlying organic pathology or bleeding disorders...
  3. ncbi Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
    Obstet Gynecol 116:625-32. 2010
    ..To compare the efficacy and safety of the levonorgestrel-releasing intrauterine system and oral medroxyprogesterone acetate in the treatment of idiopathic heavy menstrual bleeding...
  4. ncbi Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32209, USA
    Contraception 74:90-9. 2006
    ..This 7-year, prospective, matched-cohort, clinical study evaluated the effects of intramuscular depot medroxyprogesterone acetate (DMPA) (150 mg/mL) on bone mineral density (BMD) in women aged 25-35 years...
  5. ncbi Enhancing oral contraceptive success: the potential of new formulations
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32209, USA
    Am J Obstet Gynecol 190:S23-9. 2004
    ..Further experience with this formulation will determine its role in contraceptive practice...
  6. ncbi Progestin-releasing intrauterine systems and leiomyoma
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, FL 32209, USA
    Contraception 75:S130-3. 2007
    ....
  7. ncbi Gynecologic problems of the perimenopause: evaluation and treatment
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209, USA
    Obstet Gynecol Clin North Am 29:455-73. 2002
    ..By heeding the evidence-based approaches to evaluation and treatment described herein, clinicians can improve the health and lives of their perimenopausal patients...
  8. ncbi Noncontraceptive health benefits of oral contraceptives
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32257, USA
    Rev Endocr Metab Disord 3:277-83. 2002
  9. ncbi Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Forida College of Medicine Jacksonville, FL 32209, USA
    Menopause 14:941-3. 2007
    ..If future studies confirm the promising findings observed in this patient, use of aromatase inhibitors may prove useful in treating uterine bleeding associated with fibroids in postmenopausal women...
  10. ncbi Menstruation: choosing whether...and when
    A M Kaunitz
    University of Florida Health Science Center, Jacksonville, FL 32557, USA
    Contraception 62:277-84. 2000
    ....
  11. ncbi Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 80:7-17. 2009
    ..65 mL; DMPA-SC) and achieves highly effective contraception with a similar tolerability profile to intramuscular DMPA (150 mg/mL; DMPA-IM)...
  12. ncbi Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 77:67-76. 2008
    ....
  13. ncbi Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option
    A M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida, Jacksonville 32209, USA
    Arch Gynecol Obstet 265:119-23. 2001
    ..Studies have noted a high level of patient satisfaction with Lunelle, suggesting that monthly injectable contraception will become a first-line contraceptive option in the United States...
  14. ncbi Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Florida, USA
    Obstet Gynecol 113:1104-16. 2009
    ..To compare the effects of the levonorgestrel intrauterine system and endometrial ablation in reducing heavy menstrual bleeding...
  15. ncbi Sublingual misoprostol for labor induction: a randomized clinical trial
    Samuel B Wolf
    Department of Obstetrics and Gynecology, University of Florida Health Sciences Center Jacksonville, 653 1 West 8th Street, Jacksonville, FL 32209, USA
    Obstet Gynecol 105:365-71. 2005
    ..To compare the effectiveness of 50 microg compared with 100 microg of repetitive misoprostol dosages administered sublingually for labor induction...
  16. ncbi Current options for injectable contraception in the United States
    A M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center/Jacksonville, Jacksonville, Florida, USA
    Semin Reprod Med 19:331-7. 2001
    ..Patient counseling about the potential for these side effects, as well as possible risks, is important to long-term successful use of these contraceptive methods...
  17. ncbi Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial
    A M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, Florida 32209, USA
    Contraception 61:295-302. 2000
    ..0002) in the Cyclessa group. The contraceptive efficacy and safety of Cyclessa is comparable to Ortho-Novum 7/7/7. Cyclessa provides significantly improved cycle control with no weight gain...
  18. ncbi Contraceptive efficacy and safety of DMPA-SC
    J Jain
    Department of Obstetrics and Gynecology, University of Southern California, Keck School of Medicine, 1240 North Mission Road, Room 8K6, Los Angeles, CA, USA
    Contraception 70:269-75. 2004
    ..DMPA-SC was well-tolerated and adverse events were similar to those reported previously with Depo-Provera IM. Thus, DMPA-SC offers women a new, highly effective and convenient long-acting contraceptive option...
  19. ncbi Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery
    L Sanchez-Ramos
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL, USA
    Int J Gynaecol Obstet 83:151-7. 2003
    ..To determine whether human chorionic gonadotropin (hCG) detected in cervicovaginal secretions of patients with symptoms suggestive of preterm labor is a predictor of preterm birth...
  20. ncbi Misoprostol use during the third stage of labor
    S D Joy
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, FL, USA
    Int J Gynaecol Obstet 82:143-52. 2003
    ..To systematically review the efficacy of misoprostol compared with placebo or other uterotonics in preventing maternal morbidity associated with the third stage of labor...
  21. ncbi Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: a meta-analysis
    L Sanchez-Ramos
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville 32209, USA
    Obstet Gynecol 94:878-83. 1999
    ..To systematically review published randomized trials that compared efficacy of a 10-mg, controlled-release dinoprostone vaginal insert with other prostaglandins for cervical ripening and labor induction...
  22. ncbi Route of breech delivery and maternal and neonatal outcomes
    L Sanchez-Ramos
    Department of Obstetrics and Gynecology, University of Florida Health Sciences Center, Jacksonville, FL, USA
    Int J Gynaecol Obstet 73:7-14. 2001
    ..To compare maternal and neonatal outcomes in elective cesarean vs. attempted vaginal delivery for breech presentation at or near term...
  23. ncbi Sonographic cervical assessment to predict the success of labor induction: a systematic review with metaanalysis
    Ann S Hatfield
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Am J Obstet Gynecol 197:186-92. 2007
    ..The purpose of this investigation was to review the literature that evaluates sonographic cervical assessment to predict successful induction of labor...
  24. ncbi Long-acting contraceptives in adolescents
    Lama L Tolaymat
    Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, Florida 32207, USA
    Curr Opin Obstet Gynecol 19:453-60. 2007
    ..To help clinicians guide adolescent patients to sound choices regarding long-acting contraceptives. The safety, side effects and non-contraceptive benefits of injectable, implantable and intrauterine contraception are detailed...
  25. ncbi Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, Jacksonville, Florida, USA
    Manag Care Interface 20:47-50. 2007
    ..In particular, the levonorgestrel-releasing intrauterine system (LNG-IUS), a nonsurgical, reversible treatment, provides effective management for many women with menorrhagia while minimizing morbidity and health care costs...
  26. ncbi Current concepts regarding use of DMPA
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center, 655 West Eighth Street, Jacksonville, FL 32209, USA
    J Reprod Med 47:785-9. 2002
    ..In this overview, the goal is to evaluate objective data in the context of practical management...
  27. ncbi The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial
    Luis Sanchez-Ramos
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Florida Health Science Center, Jacksonville, Florida 32209, USA
    Obstet Gynecol 99:1080-4. 2002
    ..To estimate whether a dosage of 50 microg of misoprostol tablets moistened with 3% acetic acid and administered intravaginally is more efficacious for labor induction than a similar dosage regimen using dry tablets...
  28. ncbi Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review
    Luis Sanchez-Ramos
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Florida Health Science Center, Jacksonville, Florida 32209, USA
    Obstet Gynecol 99:145-51. 2002
    ..To systematically review published randomized controlled trials (RCTs) to compare the safety and efficacy of 25 microg versus 50 microg of intravaginal misoprostol for cervical ripening and labor induction...
  29. ncbi Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review
    Jennifer Heinemann
    Department of Obstetrics and Gynecology University of Florida Health Science Center, Jacksonville, Florida 32209, USA
    Am J Obstet Gynecol 199:177-87; discussion 187-8. 2008
    ..Compared with the use of pharmacologic agents alone, maternal and neonatal infectious morbidity appears to be increased when mechanical agents are used for cervical ripening...
  30. ncbi Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians
    Sarah Paschall
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 78:370-6. 2008
    ..This FDA labeling change has the potential to impact how this contraceptive is used. Our goal was to assess the impact of the FDA decision on how Florida obstetrician-gynecologists prescribe DMPA...
  31. ncbi Use of hormonal contraception in adolescents: skeletal health issues
    Lama L Tolaymat
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
    Curr Opin Obstet Gynecol 21:396-401. 2009
    ..To summarize the current literature regarding the effects of hormonal contraceptives on adolescents' bone health...
  32. ncbi Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis
    Luis Sanchez-Ramos
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, 653 1 West 8th Street, Jacksonville, FL 32209, USA
    Obstet Gynecol 114:631-40. 2009
    ..To appraise critically the diagnostic accuracy of cervicovaginal fetal fibronectin as a short-term predictor of preterm birth in patients with signs and symptoms of preterm labor...
  33. ncbi Maternal death caused by midgut volvulus after bariatric surgery
    Paul V Loar
    Department of Obstetrics and Gynecology, The University of Florida Health Science Center, Jacksonville, FL, USA
    Am J Obstet Gynecol 193:1748-9. 2005
    ..A 31-year-old woman with a history of laparoscopic Roux-en-Y gastric bypass surgery presented at 25 6/7 weeks' gestation with complaints of abdominal pain. Maternal death followed midgut volvulus, perforation, and septic shock...
  34. ncbi Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis
    Shanan M Loe
    Department of Obstetrics and Gynecology, University of Florida Health Sciences Center, Jacksonville, 32209, USA
    Obstet Gynecol 106:173-9. 2005
    ..To systematically review and summarize the medical literature regarding the effects of tocolysis with indomethacin on neonatal outcome...
  35. ncbi Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials
    Luis Sanchez-Ramos
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Florida Health Science Center, 653 1 West 8th Street, Jacksonville, FL 32209, USA
    Obstet Gynecol 105:273-9. 2005
    ..To perform an updated systematic review with meta-analysis to further elucidate the efficacy of progestational agents for the prevention of preterm births in patients at elevated risk...
  36. ncbi Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis
    Luis Sanchez-Ramos
    Department of Obstetrics and Gynecology, University of Florida, Jacksonville, Florida, USA
    Obstet Gynecol 101:1312-8. 2003
    ..To compare routine labor induction with expectant management for patients who reach or exceed 41 weeks' gestation...
  37. ncbi Clinical characteristics of patients with an abnormal clomiphene citrate challenge test
    Ana B Tobar Hicks
    Department of Obstetrics and Gynecology, University of Florida, Jacksonville, FL, USA
    Am J Obstet Gynecol 189:348-52; discussion 352-3. 2003
    ..The study was undertaken to identify the clinical characteristics associated with an abnormal clomiphene citrate challenge (CC) test...
  38. ncbi Expectant management versus labor induction for suspected fetal macrosomia: a systematic review
    Luis Sanchez-Ramos
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Florida, Jacksonville, Florida 32209, USA
    Obstet Gynecol 100:997-1002. 2002
    ..To systematically review and summarize the medical literature regarding the effects of expectant management and labor induction on mode of delivery and perinatal outcomes in patients with suspected fetal macrosomia...
  39. ncbi Clinical manifestations of rotavirus infection in the neonatal intensive care unit
    Renu Sharma
    Department of Pediatrics, University of Florida Health Science Center, Jacksonville, USA
    Pediatr Infect Dis J 21:1099-105. 2002
    ....
  40. ncbi Beyond the pill: new data and options in hormonal and intrauterine contraception
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida Health Science Center/Jacksonville, Jacksonville, FL, USA
    Am J Obstet Gynecol 192:998-1004. 2005
    ..Last, I will look over the horizon and briefly describe potential future methods that include the single rod progestin-releasing implant, folic acid-supplemented oral contraceptives, and hormonal contraception for men...
  41. ncbi Oral contraceptive use in perimenopause
    A M Kaunitz
    Gynecology, Menopause and Bone Density Services, Medicus Diagnostic Center, Department of Obstetric and Gynecology, University of Florida Health Science Center, Jacksonville, FL 32209, USA
    Am J Obstet Gynecol 185:S32-7. 2001
    ..Oral contraceptives can be viewed as a strategy not only to improve perimenopausal symptoms, provide effective contraception, and reduce some long-term health risks, but also to enhance the quality of life for perimenopausal women...
  42. ncbi Pharmacy access to emergency hormonal contraception in Jacksonville, FL: a secret shopper survey
    Amy C French
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 75:126-30. 2007
    ..We evaluated one aspect of access--pharmacy availability of levonorgestrel EC (Plan B) or alternatives--in Jacksonville, FL...
  43. ncbi Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine Jacksonville, Jacksonville, FL 32209, USA
    Contraception 79:350-5. 2009
    ....
  44. ncbi The oncogenic potential of endometrial polyps: a systematic review and meta-analysis
    Stephanie Cruz Lee
    Department of Obstetrics and Gynecology, The Family Birth Place at St Luke s Hospital, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
    Obstet Gynecol 116:1197-205. 2010
    ..To systematically review and summarize the medical literature regarding the association of menopausal status, uterine bleeding, and polyp size and risk of malignancy among women undergoing polyp resection...
  45. ncbi The hormone continuum: accrual of women's health benefits
    E S Linn
    Department of Obstetrics and Gynecology, Advocate Lutheran General Hospital, Park Ridge, Illinois 60068, USA
    Int J Fertil Womens Med 46:60-72. 2001
    ..This paper discusses risks as well as benefits of hormone therapy, especially of HRT, with an emphasis on patient counseling and individualizing of therapy...
  46. ncbi Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial
    C Pitt
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Florida Health Science Center, Jacksonville, Florida 32209, USA
    Obstet Gynecol 98:745-50. 2001
    ..CONCLUSION: The preoperative administration of 5 g of intravaginal metronidazole gel appears to reduce the incidence of postcesarean endometritis...
  47. ncbi Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials
    Daniel R Mishell
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 75:11-5. 2007
    ..This manuscript provides recommendations regarding best practices in trial design, data collection and analysis regarding bleeding data in combined hormone contraception trials...
  48. ncbi Clinical practice. Hormonal contraception in women of older reproductive age
    Andrew M Kaunitz
    Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Jacksonville, USA
    N Engl J Med 358:1262-70. 2008
  49. ncbi Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy
    Murray Freedman
    Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA, USA
    Menopause 16:735-41. 2009
    ..The aim of this study was to evaluate low-dose synthetic conjugated estrogens A (SCE-A) cream administered twice weekly for the treatment of moderate to severe vulvovaginal atrophy (VVA) in a symptomatic postmenopausal population...
  50. ncbi Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception
    Daniel R Mishell
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Contraception 75:4-10. 2007
    ....
  51. ncbi Randomized trial to compare perioperative outcomes of Filshie clip vs. Pomeroy technique for postpartum and intraoperative cesarean tubal sterilization: a pilot study
    Bettina A Kohaut
    Department of Obstetrics and Gynecology, University of Florida Health Science Center/Jacksonville, 3627 University Boulevard South, Suite #355, Jacksonville, FL 32216, USA
    Contraception 69:267-70. 2004
    ..In addition, operating time was shorter for the Filshie clip. This pilot study suggests that use of the Filshie clip technique has the potential to establish a new standard of care for postpartum and intrapartum cesarean sterilization...
  52. ncbi Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine
    Barbara A Cromer
    Case School of Medicine, Cleveland, Ohio, USA
    J Adolesc Health 39:296-301. 2006
    ....
  53. ncbi Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial
    Felicia H Stewart
    University of California San Francisco, Center for Reproductive Health Research and Policy, San Francisco, California, USA
    Obstet Gynecol 105:1389-96. 2005
    ..This regimen may represent a useful alternative for women who prefer fewer episodes of withdrawal bleeding...
  54. ncbi Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    JAMA 290:1739-48. 2003
    ..The effects of continuous combined hormone therapy on gynecologic cancers have not been investigated previously in a randomized trial setting...
  55. ncbi Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative
    Andrew M Kaunitz
    University of Florida Health Science Center/Jacksonville, USA
    Medscape Womens Health 7:8. 2002
  56. ncbi Long-acting hormonal contraceptives--indispensable in preventing teen pregnancy
    Andrew M Kaunitz
    J Adolesc Health 40:1-3. 2007
  57. ncbi Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance
    Andrew M Kaunitz
    Circulation 107:e67-8; author reply e67-8. 2003
  58. ncbi Hormone therapy and breast cancer risk: trumping fear with facts
    Andrew M Kaunitz
    Menopause 13:160-3. 2006
  59. ncbi Hormone replacement therapy: where do we go now?
    Andrew M Kaunitz
    Breast J 8:329-31. 2002
  60. ncbi Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives
    Linda C Andrist
    Graduate Program in Nursing, MGH Institute of Health Professions, Boston, MA 02129, USA
    Contraception 70:359-63. 2004
    ..Results demonstrate that providers need to discuss this option with their patients...
  61. ncbi Depo-Provera's black box: time to reconsider?
    Andrew M Kaunitz
    Contraception 72:165-7. 2005